SKAN Group AG
SIX:SKAN

Watchlist Manager
SKAN Group AG Logo
SKAN Group AG
SIX:SKAN
Watchlist
Price: 74.6 CHF -0.8%
Market Cap: 1.7B CHF
Have any thoughts about
SKAN Group AG?
Write Note

SKAN Group AG
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SKAN Group AG
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
SKAN Group AG
SIX:SKAN
Income from Continuing Operations
CHf27.9m
CAGR 3-Years
34%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Bachem Holding AG
SIX:BANB
Income from Continuing Operations
CHf113.6m
CAGR 3-Years
5%
CAGR 5-Years
18%
CAGR 10-Years
16%
Siegfried Holding AG
SIX:SFZN
Income from Continuing Operations
CHf128.8m
CAGR 3-Years
23%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Lonza Group AG
SIX:LONN
Income from Continuing Operations
CHf574m
CAGR 3-Years
4%
CAGR 5-Years
-2%
CAGR 10-Years
12%
Tecan Group AG
SIX:TECN
Income from Continuing Operations
CHf101.3m
CAGR 3-Years
-12%
CAGR 5-Years
9%
CAGR 10-Years
N/A
PolyPeptide Group AG
SIX:PPGN
Income from Continuing Operations
-€51.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

SKAN Group AG
Glance View

Market Cap
1.7B CHF
Industry
Life Sciences Tools & Services

SKAN Group AG engages in the development, design, and manufacture of process isolators for the aseptic filling of biopharmaceutical products. The company is headquartered in Allschwil, Basel-Landschaft. The company went IPO on 2007-04-05. The company concentrates on companies from the industry, micro and medical technology, processing and material technology, information technology and related services. Target enterprises are those being in special situations, such as management buy-out and buy-in, changes in shareholders’ structure, succession financing, as well as coming through growth or expansion phase. The firm acts as an entrepreneurial partner in the long term. Operational activities are delegated to the independent advisor BV Partners AG. BV Holding AG and BV Partners AG form the BVgroup. As of December 31, 2011, its investment portfolio included nine companies: Covalys BioSciences AG, E2E Technologies Ltd., Lonstroff Holding AG, Piexon AG, POLYDATA AG, SKAN Holding AG, Sphinx Werkzeuge AG, Ypsomed Holding AG and Ziemer Group AG.

SKAN Intrinsic Value
93.59 CHF
Undervaluation 20%
Intrinsic Value
Price

See Also

What is SKAN Group AG's Income from Continuing Operations?
Income from Continuing Operations
27.9m CHF

Based on the financial report for Dec 31, 2023, SKAN Group AG's Income from Continuing Operations amounts to 27.9m CHF.

What is SKAN Group AG's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
37%

Over the last year, the Income from Continuing Operations growth was 30%. The average annual Income from Continuing Operations growth rates for SKAN Group AG have been 34% over the past three years , 37% over the past five years .

Back to Top